Chennai (Tamil Nadu) [India] Surgical oncologists at Apollo Cancer Center (ACC), Chennai, have successfully performed India's first robotic cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface cancer. This is a minimally invasive, robot-assisted approach. A paradigm shift in the treatment of pseudomyxoma peritonei (PMP), an aggressive appendix cancer, provides patients with a new standard of care, leading to faster recoveries and improved quality of life. A 51-year-old female patient was diagnosed with bilateral ovarian masses and required extensive surgical intervention. , which involved removal of the uterus, ovarian appendix, and part of the omentum, subsequent histopathological examination revealed a high-grade mucinous tumor of the appendix with pseudomyxoma peritonei (PMP), necessitating additional surgery.The patient was found to have residual mucinous implants (gelatinous deposits that remain in the abdomen after surgery for appendicular mucinous tumors) in the pelvis and around the cecum (the first part of the colon), due to the peculiar tendency of appendix cancer to thicken the lining of the patient's abdomen (peritoneum. ) extends to. , Dr. Ajit Pai and team performed minimally invasive robotic cytoreductive surgery (to reduce the amount of cancer cells in the abdominal cavity) along with right hemicolectomy (removal of the colon containing the appendix) and complete mesocolic excision (removal of cancer arising from the colon). surgery) performed for treatment. and appendix) and peritonectomy and total omentectomy with hyperthermic intraperitoneal chemotherapy (warm chemotherapy with chemo drug), eliminating any possible microscopic residual tumor inside the abdomen. Traditionally, CRS/HIPEC is performed through an open, 10-12 in. And it has been carried out as a comprehensive operation. Incision associated with prolonged hospitalization. The robotic CRS approach offers significant advantages because it is minimally invasive, with physicians using small 8 mm incisions for the robotic instruments to minimize pain, blood loss, scarring, and discomfort.Additionally, a single SCM (sternocleidomastoid) incision was used for tumor removal and delivery. Of HIPEC. With this innovative approach, the patient gets faster recovery and returns to normal life quickly. After one year of follow-up, he is absolutely healthy and cancer-free.